Evaluation of a Novel Eating Disorder Prevention Program (Australian Diabetes Body Project) for Young Women with Type 1 Diabetes in a Clinic Setting: A Randomized Controlled Trial.

INTERVENTION: The Australian Diabetes Body Project (ADBP) is a virtual, group‐oriented, co‐led (clinician and peer) ED prevention program based on cognitive dissonance theory. The ADBP will involve six, one‐hour, virtual sessions held over si Xconsecutive weeks. The group sessions will have two facilitators; a clinician (psychologist) and a peer‐educator with T1D. Groups will include up to 8 participants, and will be held at various times throughout the year. In between the sessions, participants will complete homework exercises to be discussed at the following session.The topics for the si Xsessions are as follows: 1. Define the ideal and explore its origin 2. Examine the costs of pursuing this ideal 3. Explore ways to resist pressures to be thin 4. Discuss how to challenge our personal body image concerns 5. Learn new ways to talk more positively about our bodies. 6. Discuss how to promote a positive relationship with diabetes and insulin. Adherence to the group sessions will be monitored by the group facilitators. Participants who fail to attend group sessions will be followed up by a facilitator or research team member. CONDITION: Diabetes Type 1;Eating disorders; ; Diabetes Type 1 ; Eating disorders Mental Health ‐ Eating disorders Metabolic and Endocrine ‐ Diabetes PRIMARY OUTCOME: Body Dissatisfaction[Body Dissatisfaction Scale (BDS); Ideal‐Body Stereotype Scale ‐ Revised (IBSS‐R) Measured at baseline, post‐intervention (six weeks), three months follow‐up. The primary time‐point for analysis will be three months. ] Eating disorder symptoms[Eating Disorder Examination Questionnaire (EDE‐Q); Diabetes Eating Problem Survey ‐ Revised (DEPS‐R) Measured at baseline, post‐intervention (six weeks), three months follow‐up. The primary time‐point for analysis will be three months. ] SECONDARY OUTCOME: Anxiety and depression symptoms will be measured as a composite secondary outcome.[Patient Health Questionnaire (PHQ‐4) Measured at baseline, post‐intervention (si Xweeks), three months follow‐up. ] Diabetes distress[Problem Areas In Diabetes (PAID) Scale ; DAWN2 Impact of Diabetes Profile (DAWN‐DIDP) Measured at baseline, post‐intervention (si Xweeks), three months follow‐up. ] Diabetes management[Medical data extraction of Glycated haemoglobin (HbA1c). Measured at baseline, post‐intervention (si Xweeks), three months follow‐up. ] Health‐related quality of life[World Health Organisation 5‐item scale (WHO‐5) Measured at baseline, post‐intervention (si Xweeks), three months follow‐up. ] INCLUSION CRITERIA: 1) Female 2) Age 15‐25 3) Greater than 6 months post diagnosis of T1D 4) Administering insulin 5) Without ED‐related hospitalisations in the prior 12 months 6) Answered “yes” to the question “do you have any body image concerns?” 7) Able to read and write English to a proficient level (that would impair their ability to complete online surveys). 8) Able to provide informed consent (those under 18 years of age must agree to participate, and also have a parent or guardian who will provide informed consent).